SCHEMBL2927486

SCHEMBL2927486

CCN(CC)C(C)c1ccc2cc(N)ccc2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.47
LMNA P02545 2/20 0.47
POLB P06746 1/20 0.47
CASP6 P55212 1/20 0.47
PLAU P00749 1/20 0.46
HTT P42858 2/20 0.38
MEN1 O00255 1/20 0.38
F2 P00734 1/20 0.38
CHRM2 P08172 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
MAOA P21397 1/20 0.38
DRD1 P21728 1/20 0.38
ACHE P22303 1/20 0.38
PTGS1 P23219 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
OPRM1 P35372 1/20 0.38
DRD3 P35462 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27314053 0.79 KDM4E (0.58) KDM4ELMNAPOLBCASP6PLAU
SCHEMBL22926836 0.70 KDM4E (0.47) KDM4ELMNAPOLBCASP6PLAU
SCHEMBL2927123 0.69 LMNA (0.50) KDM4ELMNAPOLBCASP6PLAU
SCHEMBL7454652 0.68 KDM4E (0.58) KDM4ELMNAPOLBCASP6PLAU
SCHEMBL14909222 0.68 LMNA (0.53) KDM4ELMNAPOLBCASP6PLAU
SCHEMBL14910134 0.68 KDM4E (0.53) KDM4ELMNAPOLBCASP6PLAU
SCHEMBL22926838 0.68 TLR8 (0.49) KDM4ELMNAPOLBCASP6PLAU
SCHEMBL2926228 0.68 LMNA (0.49) KDM4ELMNAPOLBCASP6PLAU
SCHEMBL14914726 0.68 KDM4E (0.45) KDM4ELMNAPOLBCASP6PLAU
SCHEMBL14910383 0.68 TLR8 (0.52) KDM4ELMNAPOLBCASP6PLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1285651-B1 MELANIN CONCENTRATING HORMONE ANTAGONISTS TAKEDA PHARMACEUTICAL (JP) 2010-09-01 EP disclosed
US-6930185-B2 Melanin-concentrating hormone antagonist TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-08-16 US disclosed
US-20040077628-A1 Melanin-concentrating hormone antagonist TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-04-22 US disclosed
EP-1285651-A1 MELANIN CONCENTRATING HORMONE ANTAGONISTS Takeda Chemical Industries, Ltd. (JP) 2003-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077628-A1 Melanin-concentrating hormone antagonist MCHR1, MC1R, MCHR2 KDM4E 2403/4885LMNA 4113/4885POLB 3619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.